£70.75

It has never been this cheap. We have no record of a lower price.

£71 today · cheaper than every other day in the last 3 months

Oncogenesis of Lymphoma

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 17 days · 17 data points (no recent data)

Historical
Generating forecast…
£70.75 £67.21 £68.63 £70.04 £71.46 £72.87 £74.29 11 August 2026 15 August 2026 19 August 2026 23 August 2026 27 August 2026
View at Amazon ↗

Price data last checked 74 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 17 days • 1 price levels

Days at Price
17 days 0 4 9 13 17 £71 Days at Price

Price Analysis

Most common price: £71 (17 days, 100.0%)

Price range: £71 - £71

Price levels: 1 different prices over 17 days

Description
This Special Issue on the topic of the oncogenesis of lymphoma focuses on three major areas of research: viral oncogenesis, molecular mechanisms of transformation, and putative microbial drivers. The section on viral oncogenesis highlights the role of the Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) in lymphoid malignancies. Contributions discuss EBV-positive classic Hodgkin lymphoma in immunodeficient hosts, the interplay between EBV and MYC in Burkitt lymphoma, and KSHV-mediated signaling alterations in primary effusion lymphoma and multicentric Castleman disease. Another review addresses lymphoproliferative disorders in people living with HIV, examining clinical heterogeneity and emerging immunotherapeutic strategies. The molecular transformation section examines the progression of indolent B-cell malignancies to aggressive lymphomas, emphasizing genetic lesions and immune dysregulation. Additional articles explore the relevance of TNF family receptors in classic Hodgkin lymphoma, the impact of c-MYC overexpression and IGH rearrangements in chronic lymphocytic leukemia, and integrated genomic-TCR profiling to refine diagnosis and prognosis in early mycosis fungoides. Finally, studies on putative microbial drivers investigate the contribution of skin dysbiosis-particularly toxin-producing Staphylococcus aureus-to T-cell activation in mycosis fungoides, and microbiome features in breast implant-associated anaplastic large cell lymphoma, supporting multifactorial rather than pathogen-specific etiologies.

Product Specifications
Format
hardcover
ASIN
3725866848
Category
Books > Subjects > Science, Nature & Maths > Biological Sciences > Biological Science
Domain
Amazon UK
Release Date
12 February 2026
Listed Since
10 March 2026

Barcode

No barcode data available

Similar Products You Might Like

PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
88% match

PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer

£87.26 27 Oct 2026
Targeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles
88% match

Targeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles

£64.27 04 Nov 2026
Emerging Antibody Engineering Strategies and Applications for Immunotherapy of Cancer
86% match

Emerging Antibody Engineering Strategies and Applications for Immunotherapy of Cancer

£57.49 04 Nov 2026
Radiopharmaceuticals
86% match

Radiopharmaceuticals

£77.92 27 Oct 2026
Germ Line Mutations Associated Leukemia
86% match

Germ Line Mutations Associated Leukemia

IntechOpen

£93.77 29 Oct 2026
Novel Anticancer Strategies (Volume II)
86% match

Novel Anticancer Strategies (Volume II)

£120.38 04 Nov 2026
Indolent Lymphomas (Hematologic Malignancies)
86% match

Indolent Lymphomas (Hematologic Malignancies)

Springer

£107.85 29 Oct 2026
Hydrothermal Carbonization
86% match

Hydrothermal Carbonization

£51.91 04 Nov 2026
Cancer
85% match

Cancer

£160.28 27 Oct 2026
Plant Genomics
85% match

Plant Genomics

£92.92 26 Oct 2026
Lignocellulosic Biomass II
85% match

Lignocellulosic Biomass II

£70.41 04 Nov 2026
Treatment of Leukemia and Lymphoma
85% match

Treatment of Leukemia and Lymphoma

Academic Press

£175.00 23 Oct 2026
Monoclonal Antibodies in Oncology
85% match

Monoclonal Antibodies in Oncology

£90.00 31 Oct 2026
Ductal Carcinoma in Situ of the Breast
85% match

Ductal Carcinoma in Situ of the Breast

Springer

£95.74 22 Oct 2026
Management of Oral Cancers
85% match

Management of Oral Cancers

Springer

£88.21 27 Oct 2026
Synthesis and Characterization of Biomedical Materials
85% match

Synthesis and Characterization of Biomedical Materials

£75.66 04 Nov 2026
Lymphoma: Methods and Protocols (Methods in Molecular Biology, 2865)
85% match

Lymphoma: Methods and Protocols (Methods in Molecular Biology, 2865)

Humana

£148.69 24 Oct 2026
Vegetable Genomics and Breeding Research
85% match

Vegetable Genomics and Breeding Research

£62.49 04 Nov 2026
Immunotherapy for Gastrointestinal Cancer
84% match

Immunotherapy for Gastrointestinal Cancer

Springer

£73.14 21 Oct 2026
Neurodegenerative Disease: From Molecular Basis to Therapy
84% match

Neurodegenerative Disease: From Molecular Basis to Therapy

£77.92 05 Nov 2026
Orthopedics and Trauma in Children
84% match

Orthopedics and Trauma in Children

£63.49 04 Nov 2026
Precision Molecular Pathology of Aggressive B-Cell Lymphomas (Molecular Pathology Library)
84% match

Precision Molecular Pathology of Aggressive B-Cell Lymphomas (Molecular Pathology Library)

Springer

£95.74 21 Oct 2026
Advances in Hyperspectral Data Exploitation
84% match

Advances in Hyperspectral Data Exploitation

£80.42 24 Oct 2026
Brain-Targeted Drug Delivery
84% match

Brain-Targeted Drug Delivery

£57.67 04 Nov 2026